ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · IEX Real-Time Price · USD
9.16
+0.14 (1.55%)
At close: May 17, 2024, 4:00 PM
9.65
+0.49 (5.35%)
After-hours: May 17, 2024, 5:37 PM EDT
ORIC Pharmaceuticals Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for ORIC stock have an average target of 20.29, with a low estimate of 14 and a high estimate of 27. The average target predicts an increase of 121.51% from the current stock price of 9.16.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ORIC stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 4 | 4 | 5 | 6 | 6 | 6 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $15 → $14 | Strong Buy | Maintains | $15 → $14 | +52.84% | May 7, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $19 → $18 | Buy | Maintains | $19 → $18 | +96.51% | Mar 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $21 | Strong Buy | Maintains | $15 → $21 | +129.26% | Mar 21, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $14 → $17 | Buy | Maintains | $14 → $17 | +85.59% | Mar 12, 2024 |
| Baird | Baird | Buy Reiterates $27 → $25 | Buy | Reiterates | $27 → $25 | +172.93% | Mar 12, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.79
from -1.96
EPS Next Year
-1.99
from -1.79
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 40.1M | 173.1M | 458.5M |
| Avg | n/a | n/a | 15.6M | 48.3M | 230.9M |
| Low | n/a | n/a | n/a | n/a | 15.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 1,006.9% | 848.4% |
| Avg | - | - | - | 209.2% | 377.5% |
| Low | - | - | - | - | -67.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.74 | -1.62 | -2.07 | -2.04 | 0.87 |
| Avg | -1.79 | -1.99 | -2.36 | -2.30 | 0.85 |
| Low | -1.79 | -2.21 | -2.56 | -2.81 | 0.81 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.